Examining Policy, Enabler And Access Factor Effects On U.S State Medicaid Pharmaceutical Utilization And Expenditures

Search for this publication on Google Scholar
EGHAN, E. M. M. A. N. U. E. L. (2021). Examining Policy, Enabler And Access Factor Effects On U.S State Medicaid Pharmaceutical Utilization And Expenditures. Unc Charlotte Electronic Theses And Dissertations.
Download PDF

Analytics

117 views ◎
85 downloads ⇓


Abstract

Prescription drug expenditures and utilization are the fastest growing and most widely varying expenditures within Medicaid programs across US states. The passage of the Affordable Care Act (ACA) in 2010 and the subsequent Medicaid state expansions resulted in very large coverage gains among several demographics. Prior to the ACA a number of studies highlighting determinants of overall healthcare utilization and expenditures had been undertaken. Most of these studies examined discreet determinants for overall health care. However, these determinants, their interactions have not been tested concurrently in relation to pharmaceutical expenditures. Data from the Centers for Medicare and Medicaid Services (CMS), US Department of Labor, Department of Education, and state Medicaid programs were merged to create a balanced panel data (n=350 observations and 53 variables over a seven (7) period from 2009 to 2015). Based on Andersen’s Behavioral Model of Health Services, and using STATA-16, a random effects (RE) panel regression analysis is undertaken to estimate an econometric model for Medicaid pharmaceutical expenditures. A Partial Least Square-Structural Equation Model is developed to examine the relationships between and test the hypothesized effects of policy, access and predisposing factors on State Medicaid expenditures. The model estimate showed a significant influence on drug expenditures of state non-drug Medicaid expenditures, proportion of males in the population, and provider education programs on generics. Discussions, limitations and future directions for research are stated

Details
Author

EGHAN, EMMANUEL

Title

Examining Policy, Enabler And Access Factor Effects On U.S State Medicaid Pharmaceutical Utilization And Expenditures

Physical Description

1 online resource (116 pages) : PDF

Date

2021

Degree Granting Institution

University of North Carolina at Charlotte

Abstract

Prescription drug expenditures and utilization are the fastest growing and most widely varying expenditures within Medicaid programs across US states. The passage of the Affordable Care Act (ACA) in 2010 and the subsequent Medicaid state expansions resulted in very large coverage gains among several demographics. Prior to the ACA a number of studies highlighting determinants of overall healthcare utilization and expenditures had been undertaken. Most of these studies examined discreet determinants for overall health care. However, these determinants, their interactions have not been tested concurrently in relation to pharmaceutical expenditures. Data from the Centers for Medicare and Medicaid Services (CMS), US Department of Labor, Department of Education, and state Medicaid programs were merged to create a balanced panel data (n=350 observations and 53 variables over a seven (7) period from 2009 to 2015). Based on Andersen’s Behavioral Model of Health Services, and using STATA-16, a random effects (RE) panel regression analysis is undertaken to estimate an econometric model for Medicaid pharmaceutical expenditures. A Partial Least Square-Structural Equation Model is developed to examine the relationships between and test the hypothesized effects of policy, access and predisposing factors on State Medicaid expenditures. The model estimate showed a significant influence on drug expenditures of state non-drug Medicaid expenditures, proportion of males in the population, and provider education programs on generics. Discussions, limitations and future directions for research are stated

Genre

doctoral dissertations

Subjects--Topics

Economics
Health services administration
Industrial management

Degree

D.B.A.

Keywords

Cost Containment
Drugs
Economics
Expenditures
Health
Pharmaceuticals

Subject Area

Business Administration

Advisor(s)

Amato, Louis
Silver, Reginald

Committee Members

Stivender, Carol
Johnson, Chandrika

Degree Note

Thesis (D.B.A.)--University of North Carolina at Charlotte, 2021.

Rights Statement

This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). For additional information, see http://rightsstatements.org/page/InC/1.0/.

Rights Holder Information

Copyright is held by the author unless otherwise indicated.

Identifier

EGHAN_uncc_0694D_12788

Permalink

http://hdl.handle.net/20.500.13093/etd:2114